IRIS
ROSSARI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.437
EU - Europa 1.113
AS - Asia 932
SA - Sud America 159
AF - Africa 17
OC - Oceania 2
Totale 3.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.386
RU - Federazione Russa 658
SG - Singapore 357
CN - Cina 237
IT - Italia 223
BR - Brasile 131
BD - Bangladesh 93
HK - Hong Kong 79
VN - Vietnam 72
DE - Germania 49
FR - Francia 43
GB - Regno Unito 36
CA - Canada 28
IN - India 26
NL - Olanda 26
JP - Giappone 22
MX - Messico 16
AR - Argentina 13
PL - Polonia 12
SE - Svezia 12
ES - Italia 9
FI - Finlandia 9
AT - Austria 7
ZA - Sudafrica 7
LT - Lituania 6
PK - Pakistan 6
CH - Svizzera 5
ID - Indonesia 5
SA - Arabia Saudita 5
TR - Turchia 5
CO - Colombia 4
GR - Grecia 4
IQ - Iraq 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
EG - Egitto 3
JM - Giamaica 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
SI - Slovenia 3
AU - Australia 2
BE - Belgio 2
HN - Honduras 2
IE - Irlanda 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
MD - Moldavia 1
MV - Maldive 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
UY - Uruguay 1
Totale 3.660
Salva come PNG Salva come JPEG
Città #
Dallas 839
Singapore 231
Moscow 120
Ashburn 94
Hong Kong 75
San Jose 60
Beijing 57
New York 55
Milan 41
Los Angeles 39
Ho Chi Minh City 26
Santa Clara 24
Orem 23
Lauterbourg 21
Rome 21
Council Bluffs 18
Munich 18
Tokyo 18
São Paulo 17
Hanoi 16
Hefei 14
Shanghai 14
Montreal 13
Poplar 13
Naples 12
Atlanta 11
Manchester 11
Denver 10
Frankfurt am Main 10
London 10
Warsaw 10
Mexico City 9
Boardman 7
Cesano Boscone 7
Chennai 7
Guangzhou 7
Monza 7
Phoenix 7
Toronto 7
Bacoli 6
Berlin 6
Biên Hòa 6
Brooklyn 6
Nuremberg 6
Secaucus 6
Stockholm 6
Amsterdam 5
Bari 5
Chicago 5
Helsinki 5
Houston 5
North Bergen 5
Boston 4
Charlotte 4
Da Nang 4
Dhaka 4
Johannesburg 4
Mumbai 4
New Delhi 4
Newark 4
Padua 4
Querétaro 4
Riyadh 4
Tianjin 4
Athens 3
Belo Horizonte 3
Buenos Aires 3
Catania 3
Ljubljana 3
Milwaukee 3
Nanning 3
Pelotas 3
Porto Alegre 3
Rio de Janeiro 3
San Francisco 3
Schafisheim 3
Shenzhen 3
São José dos Campos 3
Trieste 3
Verona 3
Vienna 3
Vilnius 3
Agadir 2
Ankara 2
Bangkok 2
Belford Roxo 2
Bologna 2
Brussels 2
Buffalo 2
Cape Town 2
Carouge 2
Changsha 2
Chengdu 2
Cleveland 2
Colombo 2
Dublin 2
Duque de Caxias 2
Falkenstein 2
Forcalquier 2
Formosa 2
Totale 2.209
Salva come PNG Salva come JPEG
Nome #
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 430
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 420
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models 173
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 136
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 131
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study 129
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 129
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents 120
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 115
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 110
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population 108
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 107
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study 105
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 104
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 103
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 99
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 98
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer 95
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 90
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 83
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 83
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 75
Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting 74
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes 73
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications 73
Treatment options for advanced hepatocellular carcinoma: the potential of biologics 73
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 70
A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice 70
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment 69
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population 67
Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf: Neutrophil-To-lymphocyte ratio and platelet-To-lymphocyte ratio 66
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 49
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population 22
null 7
Gene-based delivery of immune-activating cytokines for cancer treatment 4
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience 2
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study 2
Tumor-targeted cytokine delivery by engineered myeloid cells unlocks CAR T cell efficacy and endogenous T cell responses in glioblastoma 2
Totale 3.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202316 2 3 0 2 2 1 1 0 2 3 0 0
2023/202442 0 1 5 2 5 4 0 0 0 2 8 15
2024/2025273 18 4 3 13 20 19 30 49 21 15 19 62
2025/20263.434 157 443 589 357 253 119 164 225 636 136 175 180
Totale 3.766